AFT Pharmaceuticals Ltd
NZX:AFT
Wall Street
Price Targets
AFT Price Targets Summary
AFT Pharmaceuticals Ltd
According to Wall Street analysts, the average 1-year price target for AFT is 3.77 NZD with a low forecast of 3.13 NZD and a high forecast of 4.52 NZD.
Price Targets
Operating Income
Forecast
Operating Income Estimate
AFT Pharmaceuticals Ltd
For the last 12 years the compound annual growth rate for AFT Pharmaceuticals Ltd's operating income is 26%. The projected CAGR for the next 3 years is 38%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is AFT's stock price target?
Price Target
3.77
NZD
According to Wall Street analysts, the average 1-year price target for AFT is 3.77 NZD with a low forecast of 3.13 NZD and a high forecast of 4.52 NZD.
What is AFT Pharmaceuticals Ltd's Revenue forecast?
Projected CAGR
19%
For the last 12 years the compound annual growth rate for AFT Pharmaceuticals Ltd's revenue is 15%. The projected CAGR for the next 2 years is 19%.
What is AFT Pharmaceuticals Ltd's Operating Income forecast?
Projected CAGR
38%
For the last 12 years the compound annual growth rate for AFT Pharmaceuticals Ltd's operating income is 26%. The projected CAGR for the next 3 years is 38%.
What is AFT Pharmaceuticals Ltd's Net Income forecast?
Projected CAGR
39%
For the last 12 years the compound annual growth rate for AFT Pharmaceuticals Ltd's net income is 43%. The projected CAGR for the next 2 years is 39%.
You don't have any saved screeners yet
